ProbioMax 50 Billion: Out of Specification
Last updated
Summary
Product
ProbioMax 50 Billion
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| ProbioMax 50 Billion | ProbioMax 50 Billion | NPN 80075474 | Capsule | Bifidobacterium animalis subsp. lactis 15 billion CFU, Bifidobacterium bifidum 1 billion CFU, Bifidobacterium longum subsp. longum 1.5 billion CFU, Lacticaseibacillus paracasei 2.5 billion CFU, Lactiplantibacillus plantarum 2.5 billion CFU, Lactobacillus acidophilus 2.5 billion CFU, Lactobacillus casei 2 billion CFU, Lactobacillus gasseri 2.5 billion CFU, Lactobacillus reuteri 0.5 billion CFU, Lactobacillus rhamnosus 20 billion CFU | VA149 |
Issue
Bacteria content is below specification in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
Jamp Pharma Corporation
1310 Rue Nobel
Boucherville, QC J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-73065
Get notified
Receive notifications for new and updated recalls and alerts by category.